Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation

Publisher： John Wiley & Sons Inc

E-ISSN： 1472-8206|767-3981|5|488-498

ISSN： 0767-3981

Source： Fundamental & Clinical Pharmacology, Vol.767-3981, Iss.5, 2015-10, pp. : 488-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 5, 2015-10 ,pp. : 488-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin aspart: Lipoatrophy following continuous subcutaneous infusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Insulin aspart: Lipoatrophy following a switch to continuous subcutaneous insulin infusion in a child?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1312, 2010-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia

By Cohen Neale  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 881-897

Adis International

Access to resources Recommend Favorite

Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension

By  

Current Medicinal Chemistry, Vol. 13, Iss. 30, 2006-01 ,pp. : 3649-3661

Bentham Science Publishers

Access to resources Recommend Favorite